161 related articles for article (PubMed ID: 20824699)
21. Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa.
Shankar S; Srivastava RK
Carcinogenesis; 2007 Jun; 28(6):1277-86. PubMed ID: 17277231
[TBL] [Abstract][Full Text] [Related]
22. Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.
Yadav VR; Prasad S; Kannappan R; Ravindran J; Chaturvedi MM; Vaahtera L; Parkkinen J; Aggarwal BB
Biochem Pharmacol; 2010 Oct; 80(7):1021-32. PubMed ID: 20599780
[TBL] [Abstract][Full Text] [Related]
23. Multiple molecular targets in cancer chemoprevention by curcumin.
Thangapazham RL; Sharma A; Maheshwari RK
AAPS J; 2006 Jul; 8(3):E443-9. PubMed ID: 17025261
[TBL] [Abstract][Full Text] [Related]
24. Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase.
Pinlaor S; Ma N; Hiraku Y; Yongvanit P; Semba R; Oikawa S; Murata M; Sripa B; Sithithaworn P; Kawanishi S
Carcinogenesis; 2004 Aug; 25(8):1535-42. PubMed ID: 15059927
[TBL] [Abstract][Full Text] [Related]
25. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin.
Kim JH; Xu C; Keum YS; Reddy B; Conney A; Kong AN
Carcinogenesis; 2006 Mar; 27(3):475-82. PubMed ID: 16299382
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion.
Philip S; Bulbule A; Kundu GC
Glycoconj J; 2004; 21(8-9):429-41. PubMed ID: 15750784
[TBL] [Abstract][Full Text] [Related]
28. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
Divya CS; Pillai MR
Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
[TBL] [Abstract][Full Text] [Related]
29. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma.
Qiao Q; Jiang Y; Li G
Anticancer Drugs; 2012 Jul; 23(6):597-605. PubMed ID: 22273827
[TBL] [Abstract][Full Text] [Related]
30. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers.
Tharakan ST; Inamoto T; Sung B; Aggarwal BB; Kamat AM
Biochem Pharmacol; 2010 Jan; 79(2):218-28. PubMed ID: 19682434
[TBL] [Abstract][Full Text] [Related]
31. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.
Lin YG; Kunnumakkara AB; Nair A; Merritt WM; Han LY; Armaiz-Pena GN; Kamat AA; Spannuth WA; Gershenson DM; Lutgendorf SK; Aggarwal BB; Sood AK
Clin Cancer Res; 2007 Jun; 13(11):3423-30. PubMed ID: 17545551
[TBL] [Abstract][Full Text] [Related]
32. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells.
Han SS; Keum YS; Seo HJ; Surh YJ
J Biochem Mol Biol; 2002 May; 35(3):337-42. PubMed ID: 12297018
[TBL] [Abstract][Full Text] [Related]
33. Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.
Kwon YK; Jun JM; Shin SW; Cho JW; Suh SI
Int J Oncol; 2005 Jun; 26(6):1597-603. PubMed ID: 15870875
[TBL] [Abstract][Full Text] [Related]
34. Discovering proteins for chemoprevention and chemotherapy by curcumin in liver fluke infection-induced bile duct cancer.
Khoontawad J; Intuyod K; Rucksaken R; Hongsrichan N; Pairojkul C; Pinlaor P; Boonmars T; Wongkham C; Jones A; Plieskatt J; Potriquet J; Bethony JM; Mulvenna J; Pinlaor S
PLoS One; 2018; 13(11):e0207405. PubMed ID: 30440021
[TBL] [Abstract][Full Text] [Related]
35. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes.
Nanji AA; Jokelainen K; Tipoe GL; Rahemtulla A; Thomas P; Dannenberg AJ
Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G321-7. PubMed ID: 12388178
[TBL] [Abstract][Full Text] [Related]
36. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
[TBL] [Abstract][Full Text] [Related]
37. Chemopreventive and therapeutic effects of curcumin.
Duvoix A; Blasius R; Delhalle S; Schnekenburger M; Morceau F; Henry E; Dicato M; Diederich M
Cancer Lett; 2005 Jun; 223(2):181-90. PubMed ID: 15896452
[TBL] [Abstract][Full Text] [Related]
38. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo.
Zeng C; Zhong P; Zhao Y; Kanchana K; Zhang Y; Khan ZA; Chakrabarti S; Wu L; Wang J; Liang G
J Mol Cell Cardiol; 2015 Feb; 79():1-12. PubMed ID: 25444713
[TBL] [Abstract][Full Text] [Related]
39. Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-κB signalling in lymphoma-bearing mice.
Das L; Vinayak M
Biosci Rep; 2012 Apr; 32(2):161-70. PubMed ID: 21831045
[TBL] [Abstract][Full Text] [Related]
40. Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal BB; Kumar A; Bharti AC
Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
